|
|
|
|
|||||
|
|
|
CME Group Inc. (NASDAQ:CME) ranks among the best non-tech stocks to buy according to billionaires. Jefferies kept its Buy rating on CME Group Inc. (NASDAQ:CME) and increased its price target to $313 from $288 on July 14. Citing improved trading volumes across the majority of asset classes, the company raised its second-quarter 2025 earnings per share projection from $2.77 to $2.90.
While metals, energy, and interest rates were the main drivers of volume upside, Electronic Broking Services (EBS) and BrokerTech revenue forecasts of $73 million marginally surpassed the prior estimate of $70 million,.
Additionally, the firm reported that the average balances for cash collateral and non-cash collateral between March 1 and May 31 came in at $118.0 billion and $151.2 billion, respectively, following the implementation of a collateral fee increase by CME Group Inc. (NASDAQ:CME) on April 1.
The top derivatives marketplace in the world, CME Group Inc. (NASDAQ:CME), offers trading, clearing, and data services for a variety of key asset classes.
While we acknowledge the potential of CME as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds
Disclosure: None.
| Jul-30 | |
| Jul-28 | |
| Jul-25 | |
| Jul-24 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite